Aprea TherapeuticsAPRE
13F holders, Q4 2024 (December 31)26holders +5
4new positions
0sold out
$3.29avg. 13F price*
At the end of Q4 2024, 26 institutions reported holding Aprea Therapeutics Inc. (APRE) in their 13F filings, up 5 from Q3 2024. 4 opened new positions and 0 sold out. The largest holders were AIGH Capital Management LLC ($1.8M), Sio Capital Management, LLC ($910K) and Sphera Funds Management LTD. ($888K).
- Company
- Aprea Therapeutics Inc.
- CUSIP
- 03836J201
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $212K |
| Exits | 0 | $0 |
All 13F filers, Q3 2024 → Q4 2024: 87,753 shares bought and 10,601 shares sold, net +77,152 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 26 holders
| AIGH Capital Management LLC | 0.67% | No change | 539,300 | $1.8M |
| Sio Capital Management, LLC | 0.26% | No change | 276,603 | $910K |
| Sphera Funds Management LTD. | 0.16% | No change | 270,000 | $888K |
| Nantahala Capital Management, LLC | 0.05% | No change | 205,760 | $677K |
| Vanguard Group Inc. | 0.00% | No change | 173,842 | $570K |
| Stonepine Capital Management, LLC | 0.40% | Add +8.8% | 149,221 | $491K |
| DAFNA Capital Management LLC | 0.12% | No change | 137,174 | $451K |
| Exome Asset Management LLC | 0.32% | Reduce -6.7% | 127,960 | $420K |
| Geode Capital Management, LLC | 0.00% | Add +6.5% | 42,663 | $140K |
| Morgan Stanley | 0.00% | Add +7.6% | 36,808 | $121K |
| Landscape Capital Management, L.L.C. | 0.01% | New | 35,328 | $116K |
| Dimensional Fund Advisors LP | 0.00% | No change | 17,064 | $56K |
| LPL Financial LLC | 0.00% | New | 16,052 | $53K |
| HighTower Advisors, LLC | 0.00% | No change | 13,864 | $46K |
| BNP Paribas Financial Markets | 0.00% | New | 13,011 | $43K |
| BlackRock, Inc. | 0.00% | No change | 8,504 | $28K |
| UBS Group AG | 0.00% | Add +197733.3% | 5,935 | $20K |
| Bank of America Corp. | 0.00% | Reduce -0.0% | 4,851 | $16K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +12.4% | 1,478 | $5K |
| Group One Trading LLC | 0.00% | Reduce -61.9% | 824 | $3K |
| Mb, Levis & Associates, LLC | 0.00% | No change | 806 | $3K |
| WealthCollab, LLC | 0.00% | No change | 158 | $520 |
| Osaic Holdings, Inc. | 0.00% | Reduce -33.3% | 100 | $329 |
| SBI Securities Co., Ltd. | 0.00% | — | 40 | $132 |
| Citigroup Inc. | 0.00% | New | 24 | $79 |
| JPMorgan Chase & Co. | 0.00% | No change | 11 | $36 |
"% of holder's portfolio" is APRE's weight in each manager's 13F, not the share of Aprea Therapeutics Inc. the manager owns.